Descripción
Secondary endpoints from the magnesium and vitamin B6 RLS trial provide further evidence on sleep-related outcomes. The randomized controlled design allowed assessment of individual and combined supplement effects on Willis-Ekbom Disease symptoms.
Figure 4
ChartSource Paper
Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of restless legs syndrome: a randomized controlled clinical trial.Cite This Figure
![Figure 4: Secondary endpoints from the magnesium and vitamin B6 RLS trial provide further evidence on sleep-related outcomes. The randomized controlled design allowed assessment of individual and combined supplement effects on Willis-Ekbom Disease symptoms.]() > Source: Ali Jadidi et al. "Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of r." *BMC complementary medicine and therapies*, 2022. PMID: [36587225](https://pubmed.ncbi.nlm.nih.gov/36587225/)
<figure> <img src="" alt="Secondary endpoints from the magnesium and vitamin B6 RLS trial provide further evidence on sleep-related outcomes. The randomized controlled design allowed assessment of individual and combined supplement effects on Willis-Ekbom Disease symptoms." /> <figcaption>Figure 4. Secondary endpoints from the magnesium and vitamin B6 RLS trial provide further evidence on sleep-related outcomes. The randomized controlled design allowed assessment of individual and combined supplement effects on Willis-Ekbom Disease symptoms.<br> Source: Ali Jadidi et al. "Therapeutic effects of magnesium and vitamin B6 in alleviating the symptoms of r." <em>BMC complementary medicine and therapies</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36587225/">36587225</a></figcaption> </figure>